Metabolic syndrome, diet and exercise. SM De Sousa Best Practice & research. Clinical Obstetrics & Gynaecology 37, 140-151, 2016 | 99 | 2016 |
Impulse control disorders in dopamine agonist-treated hyperprolactinemia: prevalence and risk factors SMC De Sousa, J Baranoff, RL Rushworth, J Butler, J Sorbello, J Vorster, ... The Journal of Clinical Endocrinology & Metabolism 105 (3), e108-e118, 2020 | 59 | 2020 |
Dopa-testotoxicosis: disruptive hypersexuality in hypogonadal men with prolactinomas treated with dopamine agonists SMC De Sousa, IM Chapman, H Falhammar, DJ Torpy Endocrine 55, 618-624, 2017 | 53 | 2017 |
Pituitary hyperplasia: case series and literature review of an under-recognised and heterogeneous condition SMC De Sousa, P Earls, AI McCormack Endocrinology, diabetes & metabolism case reports 2015 (1), 2015 | 44 | 2015 |
Ipilimumab‐induced hypophysitis in melanoma patients: an A ustralian case series T Lam, MMK Chan, AN Sweeting, SMC De Sousa, A Clements, ... Internal medicine journal 45 (10), 1066-1073, 2015 | 37 | 2015 |
Fall in thyroid stimulating hormone (TSH) may be an early marker of ipilimumab-induced hypophysitis SMC De Sousa, N Sheriff, CH Tran, AM Menzies, VHM Tsang, GV Long, ... Pituitary 21, 274-282, 2018 | 34 | 2018 |
Germline variants in familial pituitary tumour syndrome genes are common in young patients and families with additional endocrine tumours SMC De Sousa, MJ McCabe, K Wu, T Roscioli, V Gayevskiy, K Brook, ... European Journal of Endocrinology 176 (5), 635-644, 2017 | 34 | 2017 |
Prolactin correction for adequacy of petrosal sinus cannulation may diminish diagnostic accuracy in Cushing's disease SMC De Sousa, AI McCormack, S McGrath, DJ Torpy Clinical Endocrinology 87 (5), 515-522, 2017 | 23 | 2017 |
Aggressive pituitary tumors and pituitary carcinomas SMC De Sousa, AI McCormack Endotext [Internet], 2022 | 21 | 2022 |
Development and validation of a targeted gene sequencing panel for application to disparate cancers MJ McCabe, MEA Gauthier, CL Chan, TJ Thompson, SMC De Sousa, ... Scientific reports 9 (1), 17052, 2019 | 21 | 2019 |
The genomic landscape of sporadic prolactinomas SMC De Sousa, PPS Wang, S Santoreneos, A Shen, CJ Yates, M Babic, ... Endocrine pathology 30, 318-328, 2019 | 18 | 2019 |
Genetic testing in endocrinology SMC De Sousa, TSE Hardy, HS Scott, DJ Torpy The Clinical Biochemist Reviews 39 (1), 17, 2018 | 15 | 2018 |
MEN4, the MEN1 Mimicker: A Case Series of three Phenotypically Heterogenous Patients With Unique CDKN1B Mutations A Seabrook, A Wijewardene, S De Sousa, T Wong, N Sheriff, AJ Gill, ... The Journal of Clinical Endocrinology & Metabolism 107 (8), 2339-2349, 2022 | 14 | 2022 |
Synchronous nesidioblastosis, endocrine microadenoma, and intraductal papillary mucinous neoplasia in a man presenting with hyperinsulinemic hypoglycemia SMC De Sousa, KS Haghighi, MR Qiu, JR Greenfield, DLT Chen Pancreas 45 (1), 154-159, 2016 | 13 | 2016 |
A contemporary clinical approach to genetic testing for heritable hyperparathyroidism syndromes SMC De Sousa, RW Carroll, A Henderson, J Burgess, RJ Clifton-Bligh Endocrine, 1-10, 2022 | 11 | 2022 |
Familial GATA6 mutation causing variably expressed diabetes mellitus and cardiac and renal abnormalities YT Du, L Moore, NK Poplawski, SMC De Sousa Endocrinology, Diabetes & Metabolism Case Reports 2019 (1), 2019 | 11 | 2019 |
Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management? SMC De Sousa Endocrine Oncology 2 (1), R31-R50, 2022 | 10 | 2022 |
Ipilimumab-induced hypophysitis: early Australian experience S De Sousa, GV Long, KT Tonks The Medical Journal of Australia 201 (4), 198-199, 2014 | 9 | 2014 |
Polycystic ovary syndrome: prognosis and risk of comorbidity T Hardy, S De Sousa, RJ Norman Future Medicine Ltd, 2013 | 9 | 2013 |
Aberrant Splicing of SDHC in Families With Unexplained Succinate Dehydrogenase-Deficient Paragangliomas SMC De Sousa, J Toubia, TSE Hardy, J Feng, P Wang, AW Schreiber, ... Journal of the Endocrine Society 4 (12), bvaa071, 2020 | 8 | 2020 |